Understanding Vivaldi's cognitive and neurobiological effects through behavioral and neuroimaging biomarker lenses: A narrative review
November 2026
Research has demonstrated that Antonio Vivaldi's Four Seasons concertos boost attention and working memory in young and older populations. Neuroimaging biomarkers derived from electroencephalography,...
Blood-based biomarkers for neurodegenerative diseases: A narrative review
November 2026
Blood-based biomarkers have revolutionized the diagnostic landscape for neurodegenerative diseases, offering accessible alternatives to invasive cerebrospinal fluid analysis and expensive neuroimaging....
Expanding landscape of tau pathology in neurological disorders: A narrative review guiding diagnostic development and targeted therapeutics
November 2026
For decades, tau pathology was synonymous with Alzheimer’s disease, where it co-occurs with amyloid-β plaques. A paradigm shift has since established that tau is the primary pathogenic driver of a diverse...
Biomarkers in chronic traumatic encephalopathy: A narrative review from pathophysiological mechanisms to clinical research
November 2026
Chronic traumatic encephalopathy is a neurodegenerative tauopathy associated with exposure to repetitive head impacts, particularly in contact sports. Despite well-defined neuropathological criteria,...
Integrated bioinformatics approach reveals potential key genetic biomarkers and therapeutic targets in Alzheimer’s disease
November 2026
Alzheimer’s disease is a complex neurodegenerative disorder that necessitates integrative approaches to elucidate the mechanisms underlying disease-associated transcriptional dysregulation. The study...
A proposed hierarchical framework of brain compensation following lower limb amputation: A cross-sectional analysis of the DEFINE (Deficit of Inhibition as a Marker of Neuroplasticity) cohort
November 2026
Limb amputation leads to profound alterations in sensorimotor and cognitive-affective function, prompting the need for adaptive neuroplasticity to preserve quality of life. However, the brain’s capacity...
Serum interleukin−21 as a biomarker for determining COVID−19 vaccination status in patients with myasthenia gravis: A cross−sectional study
November 2026
Coronavirus disease 2019 (COVID−19) infection has been reported to induce de novo autoimmune diseases in humans, including myasthenia gravis, or trigger a relapse in such diseases. The same studies...
New technology for multi-class psychiatric disorder classification: An interpretable ensemble machine learning framework using actigraphy and demographic data
Available online 17 November 2026
Accurate diagnosis of psychiatric disorders remains a critical challenge, as traditional methods often rely on subjective evaluations that may delay or misguide treatment. There is a pressing need for...
Dysregulation of cerebrospinal fluid monoamine metabolites in patients with Alzheimer's disease: A systematic review and meta-analysis
Available online 17 November 2026
Alzheimer’s disease is a progressive neurodegenerative disorder characterized by cognitive decline and complex neurotransmitter dysfunction. While cholinergic deficits are well established, increasing...
Multidimensional biomarkers for systemic diseases: A narrative review on the implications of growth differentiation factor 15 for neurological health and beyond
Available online 12 November 2026
Growth differentiation factor 15 is a unique cytokine that responds to stress and is part of the transforming growth factor-β superfamily. It serves as a commonly used biomarker because of its involvement...
Cranial pulsatility as a biomarker of cerebrovascular health: A narrative review on the Windkessel model and its clinical application
September 2026
The cerebral Windkessel (CWK) effect describes the damping mechanism of arterial pulsations within the cranio-spinal environment, a fundamental process in neuroprotection. Dysfunction of this mechanism...
Biomarkers for diabetic peripheral neuropathy: A narrative review of advanced glycation end products
September 2026
The pathophysiology of diabetic neuropathy involves hyperglycemia-induced metabolic changes, including the polyol and protein kinase C pathways and the formation of advanced glycation end products (AGEs)....
Neurobiological and neuroimaging biomarkers: A narrative review of precision medicine for diagnosing neurodegenerative disorders
September 2026
Markers provide information about brain function, structure, and activity and are often used to study neurological and psychiatric conditions. This is crucial for diseases such as Parkinson’s disease,...
Eosinophils as a biomarker for predicting stroke severity and prognosis: A systematic review and meta-analysis
September 2026
Stroke remains a leading cause of disability and mortality worldwide, with early and reliable prediction of stroke severity remaining a critical clinical challenge. This systematic review aims to evaluate...
Brain age prediction from MRI scans using deep learning: A robust multi-site framework for neurodegenerative disease biomarker development
September 2026
Brain age prediction has emerged as a promising computational biomarker for understanding healthy aging and identifying deviations associated with neurodegenerative diseases. This study constructed...
Neurodegeneration biofluid markers and postoperative delirium: Results from a prospective cohort study
September 2026
Blood biomarkers are emerging as new tools for the diagnosis of age-related cognitive disorders, and they may help to elucidate the pathophysiology of postoperative delirium. We conducted an exploratory...
Toward implementable biomarkers for corticobasal syndrome: A narrative review
Available online 12 September 2026
Corticobasal syndrome has heterogeneous underlying pathology, complicating etiologic diagnosis and enrollment in pathology-targeted trials. We performed a targeted narrative review of autopsy cohorts...
Sensitive quantitation of glial fibrillary acidic protein in human plasma and cerebrospinal fluid: Validation of single-molecule assay detection method
Available online 15 August 2026
Neurodegenerative disease biomarkers are often present at low concentrations in their native matrices; thus, accurate measurements of these biomarkers rely on ultra-high-sensitivity assays. This study...
Integrating multimodal biomarker strategies: A narrative review of molecular and characteristic imaging techniques for better monitoring of neurodegenerative diseases
June 2026
Neurodegenerative disorders, such as Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, Huntington’s disease, multiple sclerosis, neurofibromatosis, represent a diverse group of...
New insights into neurofilament and cytokine biomarkers: A narrative review
June 2026
Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy are immune-mediated neuropathies that often present with clinical uncertainty. Early and accurate diagnosis of these conditions...
Neuromarkers in bipolar disorder: A narrative review bridging neuroscience and clinical practice
June 2026
Bipolar disorder is a chronic, disabling psychiatric condition characterized by recurrent mood episodes and substantial functional impairment. Its diagnosis and management remain largely reliant on...
Gene biomarkers related to the assembly of SNARE complexes in Alzheimer’s disease: A retrospective observational study on synergistic effects and diagnostic model construction
June 2026
Studies have suggested that synaptosome associated protein 25 (SNAP25) is abundantly expressed in the brain and contains two SNARE motifs, making the investigation of its role in Alzheimer’s disease...
Spontaneous isomerization of tau is most prevalent in Alzheimer’s disease
June 2026
The exact cause of Alzheimer's disease remains unclear. Recent studies have indicated that tau isomerization is more prevalent in patients with Alzheimer’s disease than in healthy individuals. To address...
Nanosensor-based method for autism diagnosis using nitric oxide from patient-derived induced pluripotent stem cells as a biomarker
June 2026
The prevalence of autism spectrum disorder continues to increase worldwide, and diagnostic techniques and/or technologies are being developed to identify the disorder using biomarkers. Most biomarkers...
Management and neuromarkers of glioblastoma in Sub-Saharan Africa: A narrative review of published literature and regional data
Available online 24 June 2026
Glioblastoma is the most common and aggressive primary brain malignancy in adults. While therapeutic advances have improved outcomes in high-income countries, the situation in Sub-Saharan Africa remains...